MicroVention Announces Release of CLinical EValuation of WEB™ 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness Results for Ruptured and Unruptured Aneurysms

July 23, 2024 UCBN News, Syndication Comments Off on MicroVention Announces Release of CLinical EValuation of WEB™ 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness Results for Ruptured and Unruptured Aneurysms

COLORADO SPRINGS, Colo. & ALISO VIEJO, Calif.–(BUSINESS WIRE)– #SNIS2024–MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, today announced the recently published results of the CLinical EValuation of WEB 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness Results for Ruptured and Unruptured Aneurysms. The CLEVER study was a multicenter, prospective study evaluating the WEB 17 system in ruptured and unruptured aneurysms to understand th
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Related Articles

No Picture
News

Maia Closes Seed Round to Accelerate AI-Powered Medical Coding and Revenue Cycle Management for Orthopaedic Practices

June 16, 2026 UCBN News, Syndication Comments Off on Maia Closes Seed Round to Accelerate AI-Powered Medical Coding and Revenue Cycle Management for Orthopaedic Practices

LITTLETON, Colo., June 16, 2026 /PRNewswire/ — Maia, the AI-powered medical coding and revenue cycle management (RCM) platform purpose-built for orthopaedic practices, today announced the close of its seed financing round of $1.2 million. The […]